TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/01/2026
Back to search
Official data from USPTO
NEPHROCLEAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEPHROCLEAR
ST13
US500000088563718Class
5, 10
Filing
88563718
Registration
6760821
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
05/03/2026
Trademark type
Word
Nice classes
5, 10
Filing date
08/02/2019
Registration date
06/14/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2022
Last transaction
05/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/06/2021
First use in commerce
07/06/2021
Drawing code
4
Owner type
03
Owner location
Salt Lake City, UT, US
Examiner
KHAN, AHSEN M
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BIOM?RIEUX, INC.
Astute Medical, Inc.
Representatives
Martin M. Zoltick Rothwell, Figg, Ernst & Manbeck, PC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical reagents and laboratory reagents for medicalmedicinal pharmaceutical and veterinary usefor use in the preparation of in vitro diagnostic kits; diagnostic preparations for medicalmedicinal pharmaceutical and veterinary use in the field of in vitro diagnostics; immunoassay kits consisting primarily of immunological reagents for medical diagnostic use; medical diagnostic test strips for immunological analyses
Class 10
Medical instruments and apparatus used to detect markers for medical use in the field of in vitro diagnostics; medical and veterinary apparatus and instruments for diagnostic detection of biological molecules; Laboratory instruments and apparatustest kits comprised primarily of medical diagnostic apparatus used to detect markerstest stripstest cassettespipettestest tubesvialslaboratory cards for diagnostic indicator purposes for immunological analysis; immunology analyzers for in vitro diagnostic use
Publications
History of USPTO decisions and trademark events.
52 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/01/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/01/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/01/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/11/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/14/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/30/2022
GNRT
NON-FINAL ACTION E-MAILED
03/30/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/30/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/24/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/24/2022
IUAF
USE AMENDMENT FILED
02/03/2022
EISU
TEAS STATEMENT OF USE RECEIVED
02/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2022
EX4G
SOU EXTENSION 4 GRANTED
01/03/2022
EXT4
SOU EXTENSION 4 FILED
01/03/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/08/2021
EX3G
SOU EXTENSION 3 GRANTED
06/04/2021
EXT3
SOU EXTENSION 3 FILED
06/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/12/2020
EX2G
SOU EXTENSION 2 GRANTED
12/10/2020
EXT2
SOU EXTENSION 2 FILED
12/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/19/2020
EX1G
SOU EXTENSION 1 GRANTED
06/17/2020
EXT1
SOU EXTENSION 1 FILED
06/17/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/17/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2019
PUBO
PUBLISHED FOR OPPOSITION
11/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/09/2019
ALIE
ASSIGNED TO LIE
10/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/19/2019
GNRT
NON-FINAL ACTION E-MAILED
09/19/2019
CNRT
NON-FINAL ACTION WRITTEN
09/19/2019
DOCK
ASSIGNED TO EXAMINER
09/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2019
NWAP
NEW APPLICATION ENTERED
08/06/2019
Continuous trademark protection
Get notified about every new filing that threatens NEPHROCLEAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.